Institutional Ownership Corcept Therapeutics Inc (CORT)
This table provides information about the institutional ownership of Corcept Therapeutics Inc (CORT). We have compiled data on the 474 institutions that hold shares in the stock, with a total of 83.6 Million shares, which have been reported (via 13F filing form) to have a value of $6.11 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
16,539,159
shares
|
$1.21 Billion
0.01% of portfolio
|
Q2 2024
Reduced 1.71%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
9,981,968
shares
|
$730 Million
0.02% of portfolio
|
Q1 2025
Reduced 1.32%
|
|
Ingalls & Snyder LLC
New York, NY |
May 12, 2025 Q1 2025 |
7,742,584
shares
|
$566 Million
29.09% of portfolio
|
Q1 2025
Reduced 4.41%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
6,143,031
shares
|
$449 Million
1.13% of portfolio
|
Q1 2025
Reduced 0.9%
|
|
Parallel Advisors, LLC
|
Jul 07, 2025 Q2 2025 |
3,871,123
shares
|
$283 Million
5.83% of portfolio
|
Q2 2025
Reduced 2.55%
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
3,401,936
shares
|
$249 Million
0.02% of portfolio
|
Q1 2025
Reduced 4.13%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
2,260,063
shares
|
$165 Million
0.02% of portfolio
|
Q1 2025
Added 9.28%
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 13, 2025 Q1 2025 |
2,136,510
shares
|
$156 Million
0.06% of portfolio
|
Q1 2025
Added 2.79%
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
1,538,529
shares
|
$112 Million
0.01% of portfolio
|
Q1 2025
Added 21.97%
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
May 14, 2025 Q1 2025 |
1,492,227
shares
|
$109 Million
0.14% of portfolio
|
Q1 2025
Reduced 9.28%
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
May 15, 2025 Q1 2025 |
1,349,682
shares
|
$98.7 Million
0.65% of portfolio
|
Q1 2025
Reduced 1.98%
|
|
Invesco Ltd.
Atlanta, GA |
May 12, 2025 Q1 2025 |
1,246,234
shares
|
$91.1 Million
0.03% of portfolio
|
Q1 2025
Added 76.49%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
1,031,724
shares
|
$75.4 Million
0.02% of portfolio
|
Q1 2025
Reduced 1.89%
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
1,022,001
shares
|
$74.7 Million
0.02% of portfolio
|
Q1 2025
Added 0.64%
|
|
First Trust Advisors LP
Wheaton, IL |
May 14, 2025 Q1 2025 |
924,317
shares
|
$67.6 Million
0.1% of portfolio
|
Q1 2025
Reduced 13.14%
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
May 12, 2025 Q1 2025 |
751,218
shares
|
$54.9 Million
0.41% of portfolio
|
Q1 2025
Reduced 5.72%
|
|
D. E. Shaw & Co., Inc.
New York, NY |
May 15, 2025 Q1 2025 |
700,264
shares
|
$51.2 Million
0.08% of portfolio
|
Q1 2025
Reduced 21.01%
|
|
Man Group PLC
London, X0 |
May 15, 2025 Q1 2025 |
629,175
shares
|
$46 Million
0.19% of portfolio
|
Q1 2025
Added 118.55%
|
|
Cerity Partners LLC
New York, NY |
Apr 30, 2025 Q1 2025 |
614,794
shares
|
$44.9 Million
0.14% of portfolio
|
Q1 2025
Added 1.13%
|
|
Jupiter Asset Management LTD
|
May 09, 2025 Q1 2025 |
603,903
shares
|
$44.1 Million
0.71% of portfolio
|
Q1 2025
Added 8176.04%
|
|
Boston Trust Walden Corp
|
Apr 21, 2025 Q1 2025 |
584,800
shares
|
$42.7 Million
0.5% of portfolio
|
Q1 2025
Reduced 34.95%
|
|
Principal Financial Group Inc
Des Moines, IA |
Apr 28, 2025 Q1 2025 |
530,460
shares
|
$38.8 Million
0.04% of portfolio
|
Q1 2025
Added 2.54%
|
|
Aj Wealth Strategies, LLC
|
Jul 20, 2023 Q2 2023 |
509,934
shares
|
$37.3 Million
0.55% of portfolio
|
Q2 2022
Added 28.76%
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
505,347
shares
|
$36.9 Million
0.01% of portfolio
|
Q1 2025
Reduced 19.31%
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
372,653
shares
|
$27.2 Million
0.01% of portfolio
|
Q1 2025
Added 48.96%
|